ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Psychiatry

Top Psychiatry Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GLENN PRENTICE MD

Psychiatry

756

$81.7K

86
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $107

MARK OVERTON M.D.

Psychiatry

739

$43.6K

101
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $107

DIEHL SNYDER MD

Psychiatry

709

$79.4K

69
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 25%

$112
Average prescription price

Avg: $107

SHARON MARBLE M.D.

Psychiatry

696

$59.8K

57
0 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $107

CHARLES STEWART M.D.

Psychiatry

670

$67.3K

46
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$100
Average prescription price

Avg: $107

DAVID SCHMIDT M.D.

Psychiatry

656

$47.5K

80
15 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $107

SUSAN NILSON M.D.

Psychiatry

529

$54.3K

46
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $107

PAUL PERKINS M.D.

Psychiatry

413

$21K

32
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $107

DAVID MOLTZ MD

Psychiatry

390

$62.5K

30
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

77%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 25%

$160
Average prescription price

Avg: $107

JENNIFER MOGUL MD

Psychiatry

361

$32.3K

49
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$89
Average prescription price

Avg: $107

JOHN NEWCOMB M.D.

Psychiatry

310

$50.7K

36
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

97%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

83%
prescriptions for brand name drugs

Avg: 25%

$163
Average prescription price

Avg: $107

JEREMY SPIEGEL MD

Psychiatry

309

$62.7K

71
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 25%

$203
Average prescription price

Avg: $107

CYNTHIA BURNHAM DO

Psychiatry

249

$13.5K

60
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $107

MONIR MUSAVI MD

Psychiatry

123

$22.2K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 25%

$181
Average prescription price

Avg: $107

MADELINE GOODMAN DO

Psychiatry

113

$26.4K

20
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

85%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

79%
prescriptions for brand name drugs

Avg: 25%

$234
Average prescription price

Avg: $107

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank